These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

342 related articles for article (PubMed ID: 34530920)

  • 1. Human bone marrow-derived mesenchymal stromal cells cultured in serum-free media demonstrate enhanced antifibrotic abilities via prolonged survival and robust regulatory T cell induction in murine bleomycin-induced pulmonary fibrosis.
    Takao S; Nakashima T; Masuda T; Namba M; Sakamoto S; Yamaguchi K; Horimasu Y; Miyamoto S; Iwamoto H; Fujitaka K; Hamada H; Takahashi S; Nakashima A; Hattori N
    Stem Cell Res Ther; 2021 Sep; 12(1):506. PubMed ID: 34530920
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypoxia-preconditioned mesenchymal stem cells attenuate bleomycin-induced pulmonary fibrosis.
    Lan YW; Choo KB; Chen CM; Hung TH; Chen YB; Hsieh CH; Kuo HP; Chong KY
    Stem Cell Res Ther; 2015 May; 6(1):97. PubMed ID: 25986930
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oncostatin M-Preconditioned Mesenchymal Stem Cells Alleviate Bleomycin-Induced Pulmonary Fibrosis Through Paracrine Effects of the Hepatocyte Growth Factor.
    Lan YW; Theng SM; Huang TT; Choo KB; Chen CM; Kuo HP; Chong KY
    Stem Cells Transl Med; 2017 Mar; 6(3):1006-1017. PubMed ID: 28297588
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum-Free Medium Enhances the Immunosuppressive and Antifibrotic Abilities of Mesenchymal Stem Cells Utilized in Experimental Renal Fibrosis.
    Yoshida K; Nakashima A; Doi S; Ueno T; Okubo T; Kawano KI; Kanawa M; Kato Y; Higashi Y; Masaki T
    Stem Cells Transl Med; 2018 Dec; 7(12):893-905. PubMed ID: 30269426
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NMDA receptor activation inhibits the antifibrotic effect of BM-MSCs on bleomycin-induced pulmonary fibrosis.
    Li X; Li C; Tang Y; Huang Y; Cheng Q; Huang X; Zhao F; Hao C; Feng D; Xu J; Han J; Tang S; Liu W; Yue S; Luo Z
    Am J Physiol Lung Cell Mol Physiol; 2018 Sep; 315(3):L404-L421. PubMed ID: 29722562
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induced pluripotent stem cell-derived mesenchymal stem cells reverse bleomycin-induced pulmonary fibrosis and related lung stiffness.
    Chakraborty A; Wang C; Hodgson-Garms M; Broughton BRS; Frith JE; Kelly K; Samuel CS
    Biomed Pharmacother; 2024 Sep; 178():117259. PubMed ID: 39116786
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mesenchymal Stromal Cells in Animal Bleomycin Pulmonary Fibrosis Models: A Systematic Review.
    Srour N; Thébaud B
    Stem Cells Transl Med; 2015 Dec; 4(12):1500-10. PubMed ID: 26494779
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatocyte Growth Factor Is Required for Mesenchymal Stromal Cell Protection Against Bleomycin-Induced Pulmonary Fibrosis.
    Cahill EF; Kennelly H; Carty F; Mahon BP; English K
    Stem Cells Transl Med; 2016 Oct; 5(10):1307-1318. PubMed ID: 27388243
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TGF-β1-Licensed Murine MSCs Show Superior Therapeutic Efficacy in Modulating Corneal Allograft Immune Rejection In Vivo.
    Lynch K; Treacy O; Chen X; Murphy N; Lohan P; Islam MN; Donohoe E; Griffin MD; Watson L; McLoughlin S; O'Malley G; Ryan AE; Ritter T
    Mol Ther; 2020 Sep; 28(9):2023-2043. PubMed ID: 32531237
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adipose-derived mesenchymal stem cell therapy for reverse bleomycin-induced experimental pulmonary fibrosis.
    Zhao X; Wu J; Yuan R; Li Y; Yang Q; Wu B; Zhai X; Wang J; Magalon J; Sabatier F; Daumas A; Zhu WM; Zhu N
    Sci Rep; 2023 Aug; 13(1):13183. PubMed ID: 37580529
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cyclophosphamide Combined with Bone Marrow Mesenchymal Stromal Cells Protects against Bleomycin-induced Lung Fibrosis in Mice.
    Xu J; Li L; Xiong J; Zheng Y; Ye Q; Li Y
    Ann Clin Lab Sci; 2015; 45(3):292-300. PubMed ID: 26116593
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human placental mesenchymal stem cells of fetal origins-alleviated inflammation and fibrosis by attenuating MyD88 signaling in bleomycin-induced pulmonary fibrosis mice.
    Li F; Han F; Li H; Zhang J; Qiao X; Shi J; Yang L; Dong J; Luo M; Wei J; Liu X
    Mol Immunol; 2017 Oct; 90():11-21. PubMed ID: 28662409
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Histological and Physiological Studies of the Effect of Bone Marrow-Derived Mesenchymal Stem Cells on Bleomycin Induced Lung Fibrosis in Adult Albino Rats.
    Zakaria DM; Zahran NM; Arafa SAA; Mehanna RA; Abdel-Moneim RA
    Tissue Eng Regen Med; 2021 Feb; 18(1):127-141. PubMed ID: 33090319
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Resolution of bleomycin-induced murine pulmonary fibrosis via a splenic lymphocyte subpopulation.
    Kamio K; Azuma A; Matsuda K; Usuki J; Inomata M; Morinaga A; Kashiwada T; Nishijima N; Itakura S; Kokuho N; Atsumi K; Hayashi H; Yamaguchi T; Fujita K; Saito Y; Abe S; Kubota K; Gemma A
    Respir Res; 2018 Apr; 19(1):71. PubMed ID: 29690905
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mesenchymal stem cells cultured in serum-free medium ameliorate experimental peritoneal fibrosis.
    Nagasaki K; Nakashima A; Tamura R; Ishiuchi N; Honda K; Ueno T; Doi S; Kato Y; Masaki T
    Stem Cell Res Ther; 2021 Mar; 12(1):203. PubMed ID: 33757592
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human decidual mesenchymal stem cells obtained from early pregnancy attenuate bleomycin-induced lung fibrosis by inhibiting inflammation and apoptosis.
    Ning G; Guo X; Zhu K; Xu Z; Cai P; Dang Y; Lu C; Xu F; Shen R; Kang N; Zhang R; Chen K
    Int Immunopharmacol; 2024 Dec; 142(Pt B):113224. PubMed ID: 39306886
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mesenchymal stem cell engraftment in lung is enhanced in response to bleomycin exposure and ameliorates its fibrotic effects.
    Ortiz LA; Gambelli F; McBride C; Gaupp D; Baddoo M; Kaminski N; Phinney DG
    Proc Natl Acad Sci U S A; 2003 Jul; 100(14):8407-11. PubMed ID: 12815096
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human embryonic stem cell-derived mesenchymal stromal cells suppress inflammation in mouse models of rheumatoid arthritis and lung fibrosis by regulating T-cell function.
    Zhong Y; Zhu Y; Hu X; Zhang L; Xu J; Wang Q; Liu J
    Cytotherapy; 2024 Aug; 26(8):930-938. PubMed ID: 38520411
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Classical monocyte-derived macrophages as therapeutic targets of umbilical cord mesenchymal stem cells: comparison of intratracheal and intravenous administration in a mouse model of pulmonary fibrosis.
    Choi SM; Mo Y; Bang JY; Ko YG; Ahn YH; Kim HY; Koh J; Yim JJ; Kang HR
    Respir Res; 2023 Mar; 24(1):68. PubMed ID: 36870972
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Therapeutic effects and the underlying mechanism of umbilical cord-derived mesenchymal stem cells for bleomycin induced lung injury in rats].
    Li YK; Wang H; Jiang CG; Huang H; Liu J; Wang YX; Xiao FJ; Wu ZZ; Xu ZJ
    Zhonghua Jie He He Hu Xi Za Zhi; 2013 Nov; 36(11):808-13. PubMed ID: 24507390
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.